Horm Metab Res 2012; 44(12): 927-928
DOI: 10.1055/s-0032-1316322
Letter to the Editor
© Georg Thieme Verlag KG Stuttgart · New York

Response to the Article: “Primary Aldosteronism: Are We Missing the Wood for the Trees?”

G. Piaditis
1   Department of Endocrinology and Diabetes Center, “G. Gennimatas” General Hospital, Athens, Greece
,
T. Pappa
1   Department of Endocrinology and Diabetes Center, “G. Gennimatas” General Hospital, Athens, Greece
,
A. Markou
1   Department of Endocrinology and Diabetes Center, “G. Gennimatas” General Hospital, Athens, Greece
,
A. Gouli
1   Department of Endocrinology and Diabetes Center, “G. Gennimatas” General Hospital, Athens, Greece
,
L. Papanastasiou
1   Department of Endocrinology and Diabetes Center, “G. Gennimatas” General Hospital, Athens, Greece
,
G. Kaltsas
2   Department of Pathophysiology, Laikon Hospital, Athens University School of Medicine, Athens, Greece
› Author Affiliations
Further Information

Publication History

received 01 May 2012

accepted 29 May 2012

Publication Date:
12 July 2012 (online)

This letter is a short response to Dr Funder’s recent commentary on primary aldosteronism under the title “Primary aldosteronism: are we missing the wood for the trees?”. We briefly discuss recent data from our department on autonomous aldosterone secretion (AAS) and the efficacy of mineralocorticoid receptor antagonists in a group of patients with AAS, that would otherwise remain undiagnosed.

 
  • References

  • 1 Funder JW. Primary aldosteronism: are we missing the wood for the trees?. Horm Metab Res 2012; 44: 251-253
  • 2 Stowasser M, Sharman J, Leano R, Gordon RD, Ward G, Cowley D, Marwick TH. Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I. J Clin Endocrinol Metab 2005; 90: 5070-5076
  • 3 Vasan RS, Evans JC, Larson MG, Wilson PW, Meigs JB, Rifai N, Benjamin EJ, Levy D. Serum aldosterone and the incidence of hypertension in normotensive persons. N Engl J Med 2004; 351: 33-41
  • 4 Gouli A, Kaltsas G, Tzonou A, Markou A, Androulakis I, Ragkou D, Vamvakidis K, Zografos G, Kontogeorgos G, Chroussos PG, Piaditis G. High prevalence of autonomous aldosterone secretion among patients with essential hypertension. Eur J Clin Invest 2011; 41: 1227-1236
  • 5 Pappa T, Papanastasiou L, Kaltsas G, Markou A, Tsounas P, Androulakis I, Tsiavos V, Zografos G, Vamvakidis K, Samara C, Piaditis G. Pattern of adrenal hormonal secretion in patients with adrenal adenomas: the relevance of aldosterone in arterial hypertension. J Clin Endocrinol Metab 2012; 97: E537-E545
  • 6 Piaditis GP, Kaltsas GA, Androulakis II, Gouli A, Makras P, Papadogias D, Dimitriou K, Ragkou D, Markou A, Vamvakidis K, Zografos G, Chrousos G. High prevalence of autonomous cortisol and aldosterone secretion from adrenal adenomas. Clin Endocrinol (Oxf) 2009; 71: 772-778
  • 7 Markou A, Pappa T, Kaltsas G, Gouli A, Mitsakis K, Tsounas P, Prevoli A, Tsiavos V, Papanastasiou L, Zografos G, Chrousos G, Piaditis G. Evidence of autonomous aldosterone secretion in a cohort of normotensive individuals: a very high odds ratio for progression into arterial hypertension (under review).